25 participants
PET Adapted Brentuximab Vedotin and Pembrolizumab in Combination With Doxorubicin and Dacarbazine in Classic Hodgkin Lymphoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-20
- Start Date:
- 2023-12-14
- Completion:
- 2027-10-30
Conditions
- Hodgkin Lymphoma
Interventions
- DRUG
No Results Yet